BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 14587300)

  • 1. Proteolytic and non-proteolytic migration of tumour cells and leucocytes.
    Friedl P; Wolf K
    Biochem Soc Symp; 2003; (70):277-85. PubMed ID: 14587300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis.
    Wolf K; Mazo I; Leung H; Engelke K; von Andrian UH; Deryugina EI; Strongin AY; Bröcker EB; Friedl P
    J Cell Biol; 2003 Jan; 160(2):267-77. PubMed ID: 12527751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases.
    Wolf K; Müller R; Borgmann S; Bröcker EB; Friedl P
    Blood; 2003 Nov; 102(9):3262-9. PubMed ID: 12855577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biology of cell locomotion within three-dimensional extracellular matrix.
    Friedl P; Bröcker EB
    Cell Mol Life Sci; 2000 Jan; 57(1):41-64. PubMed ID: 10949580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional imaging of pericellular proteolysis in cancer cell invasion.
    Wolf K; Friedl P
    Biochimie; 2005; 87(3-4):315-20. PubMed ID: 15781318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular matrix determinants of proteolytic and non-proteolytic cell migration.
    Wolf K; Friedl P
    Trends Cell Biol; 2011 Dec; 21(12):736-44. PubMed ID: 22036198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of cancer cell invasion and plasticity.
    Wolf K; Friedl P
    Br J Dermatol; 2006 May; 154 Suppl 1():11-5. PubMed ID: 16712711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pericellular proteolysis by leukocytes and tumor cells on substrates: focal activation and the role of urokinase-type plasminogen activator.
    Kindzelskii AL; Amhad I; Keller D; Zhou MJ; Haugland RP; Garni-Wagner BA; Gyetko MR; Todd RF; Petty HR
    Histochem Cell Biol; 2004 Apr; 121(4):299-310. PubMed ID: 15042374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calpain 2 and Src dependence distinguishes mesenchymal and amoeboid modes of tumour cell invasion: a link to integrin function.
    Carragher NO; Walker SM; Scott Carragher LA; Harris F; Sawyer TK; Brunton VG; Ozanne BW; Frame MC
    Oncogene; 2006 Sep; 25(42):5726-40. PubMed ID: 16652152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMEC-1 adopt the mixed amoeboid-mesenchymal migration type during EndMT.
    Kryczka J; Przygodzka P; Bogusz H; Boncela J
    Eur J Cell Biol; 2017 Jun; 96(4):289-300. PubMed ID: 28487031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local proteolytic activity in tumor cell invasion and metastasis.
    Ludwig T
    Bioessays; 2005 Nov; 27(11):1181-91. PubMed ID: 16237672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular proteolysis in macrophage migration: losing grip for a breakthrough.
    Vérollet C; Charrière GM; Labrousse A; Cougoule C; Le Cabec V; Maridonneau-Parini I
    Eur J Immunol; 2011 Oct; 41(10):2805-13. PubMed ID: 21953638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion.
    Wolf K; Wu YI; Liu Y; Geiger J; Tam E; Overall C; Stack MS; Friedl P
    Nat Cell Biol; 2007 Aug; 9(8):893-904. PubMed ID: 17618273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic interstitial cell migration: a five-step process.
    Friedl P; Wolf K
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):129-35. PubMed ID: 19153672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolytic-antiproteolytic balance and its regulation in carcinogenesis.
    Skrzydlewska E; Sulkowska M; Koda M; Sulkowski S
    World J Gastroenterol; 2005 Mar; 11(9):1251-66. PubMed ID: 15761961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix architecture dictates three-dimensional migration modes of human macrophages: differential involvement of proteases and podosome-like structures.
    Van Goethem E; Poincloux R; Gauffre F; Maridonneau-Parini I; Le Cabec V
    J Immunol; 2010 Jan; 184(2):1049-61. PubMed ID: 20018633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tumour cell invasion by protease inhibitors: correlation with the protease profile.
    Kolkhorst V; Stürzebecher J; Wiederanders B
    J Cancer Res Clin Oncol; 1998; 124(11):598-606. PubMed ID: 9860288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer.
    DeClerck YA
    Eur J Cancer; 2000 Jun; 36(10):1258-68. PubMed ID: 10882864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pericellular proteases in angiogenesis and vasculogenesis.
    van Hinsbergh VW; Engelse MA; Quax PH
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):716-28. PubMed ID: 16469948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the role of proteases in cancer.
    Koblinski JE; Ahram M; Sloane BF
    Clin Chim Acta; 2000 Feb; 291(2):113-35. PubMed ID: 10675719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.